Sharechat Logo

HGH - Response to FMA proceedings

Tuesday 17th September 2024

Text too small?

Heartland Group Holdings Limited (Heartland) (NZX/ASX: HGH) notes that the Financial Markets Authority (FMA) has filed proceedings against a former junior Heartland Bank Limited (Heartland Bank) employee relating to alleged insider trading in shares in Heartland. The individual has today appeared in the Auckland District Court. The matters relate to alleged events in 2020 and 2021.

 

Heartland and Heartland Bank are not parties to the FMA proceedings and have cooperated with the FMA during its investigation.

 

Heartland Chair, Greg Tomlinson and Heartland Chief Executive Officer, Jeff Greenslade said Heartland is supportive of the FMA’s commitment to fair and transparent capital markets. “We take our responsibilities as a listed company very seriously. That includes having policies and procedures in place to ensure Directors and employees at all levels understand their obligations under insider trading laws.”

 

As the matter is before the courts, Heartland will be making no further comment on the FMA’s proceedings. A copy of the FMA announcement is available at www.fma.govt.nz/news/all-releases/media-releases. Questions on this matter should be addressed to the FMA.

 

– ENDS –

 

 



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

RAK - 1H26: Strong first half growth and strategic momentum
Green Cross Health Interim Results to 30 September 2025
Devon Funds Morning Note - 28 November 2025
November 28th Morning Report
Pacific Edge Appoints Chief Commercial Officer
Ryman Healthcare reports 1H26 results
Tower reports record FY25 result, increased dividends
NZ King Salmon Investments Ltd releases FY25 (Sept) results
RBNZ - OCR lowered to 2.25%
SVR - Savor Interim Results and Trading Update